Evidence map›Paper›PMID 24829414›Full record

Trial reportJournal of immunology (Baltimore, Md. : 1950)2014

IFN priming is necessary but not sufficient to turn on a migratory dendritic cell program in lupus monocytes.

Alicia Rodriguez-Pla, Pinakeen Patel, Holden T Maecker, Jose Rossello-Urgell, Nicole Baldwin, Lynda Bennett, Victoria Cantrell, Jeanine Baisch, Marilynn Punaro, Alisa Gotte and 5 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Frontiers in immunology · 2022
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Toll-like receptors in lupus nephritis.Journal of biomedical science · 2018
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Alicia Rodriguez-PlaBaylor Institute for Immunology Research, Dallas, TX 75204;
Pinakeen PatelBaylor Institute for Immunology Research, Dallas, TX 75204;
Holden T MaeckerHuman Immune Monitoring Center, Institute for Immunity, Transplantation, and Infection, Stanford University Medical Center, Stanford, CA 94305;
Jose Rossello-UrgellBaylor Institute for Immunology Research, Dallas, TX 75204;
Nicole BaldwinBaylor Institute for Immunology Research, Dallas, TX 75204;
Lynda BennettBaylor Institute for Immunology Research, Dallas, TX 75204;
Victoria CantrellBaylor Institute for Immunology Research, Dallas, TX 75204;
Jeanine BaischBaylor Institute for Immunology Research, Dallas, TX 75204;
Marilynn PunaroDivision of Pediatric Rheumatology, Texas Scottish Rite Hospital for Children, Dallas, TX 75219; and University of Texas Southwestern Medical Center, Dallas, TX 75235.
Alisa GotteDivision of Pediatric Rheumatology, Texas Scottish Rite Hospital for Children, Dallas, TX 75219; and University of Texas Southwestern Medical Center, Dallas, TX 75235.
Lorien NassiDivision of Pediatric Rheumatology, Texas Scottish Rite Hospital for Children, Dallas, TX 75219; and University of Texas Southwestern Medical Center, Dallas, TX 75235.
Tracey WrightDivision of Pediatric Rheumatology, Texas Scottish Rite Hospital for Children, Dallas, TX 75219; and University of Texas Southwestern Medical Center, Dallas, TX 75235.
Anna Karolina PaluckaBaylor Institute for Immunology Research, Dallas, TX 75204;
Jacques BanchereauBaylor Institute for Immunology Research, Dallas, TX 75204;
Virginia PascualBaylor Institute for Immunology Research, Dallas, TX 75204; Division of Pediatric Rheumatology, Texas Scottish Rite Hospital for Children, Dallas, TX 75219; and VirginiP@Baylorhealth.edu.
Baylor University · USTexas Scottish Rite Hospital for Children · USInstitute of Infection and Immunity · CAPediatrics and Genetics · USThe University of Texas Southwestern Medical Center · US

Funding

SLAM Genes-from Mouse to ManP50AR055503 · NIAMS · UT SOUTHWESTERN MEDICAL CENTER · PI LI, QUAN · 2007 to 2011
$8.3M
Scientific CoreU19AI082715 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI PASCUAL, MARIA VIRGINIA · 2009 to 2018
$6.4M
Neutrophils in Lupus PathogenesisP50AR054083 · NIAMS · BAYLOR RESEARCH INSTITUTE · PI NUSSENZWEIG, MICHEL C · 2006 to 2010
$6.2M
NIAID NIH HHS U19 AI082715NIAMS NIH HHS AR054083-01NIAMS NIH HHS P50 AR055503PHS HHS P50055503
6 · The paper itself

Abstract

Blood monocytes from children with systemic lupus erythematosus (SLE) behave similar to dendritic cells (DCs), and SLE serum induces healthy monocytes to differentiate into DCs in a type I IFN-dependent manner. In this study, we found that these monocytes display significant transcriptional changes, including a prominent IFN signature, compared with healthy controls. Few of those changes, however, explain DC function. Exposure to allogeneic T cells in vitro reprograms SLE monocytes to acquire DC phenotype and function, and this correlates with both IFN-inducible (IP10) and proinflammatory cytokine (IL-1β and IL6) expression. Furthermore, we found that both IFN and SLE serum induce the upregulation of CCR7 transcription in these cells. CCR7 protein expression, however, requires a second signal provided by TLR agonists such as LPS. Thus, SLE serum "primes" a subset of monocytes to readily (<24 h) respond to TLR agonists and acquire migratory DC properties. Our findings might explain how microbial infections exacerbate lupus.

Indexed as

AdolescentAdultCell MovementChildCytokinesDendritic CellsFemaleHumansInterferon Type ILipopolysaccharidesLupus Erythematosus, SystemicReceptors, CCR7Toll-Like ReceptorsCCR7 protein, humanCytokinesInterferon Type ILipopolysaccharidesReceptors, CCR7Toll-Like Receptors

Identifiers

PMID24829414
PMCPMC5467885
OpenAlexW1540682053

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.